SCHEMBL29930610

SCHEMBL29930610

O=C(NCc1n[nH]c(-c2cccs2)n1)c1ccccc1N1CCC(F)(F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 2/20 0.39
GRK6 P43250 1/20 0.37
CHEK1 O14757 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 1/20 0.37
PBK Q96KB5 3/20 0.36
PKM P14618 1/20 0.36
ERCC1 P07992 1/20 0.35
FEN1 P39748 1/20 0.35
ERCC4 Q92889 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23611763 1.00 HPGD (0.41) HPGDCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL23623266 0.95 HPGD (0.40) HPGDCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL23623298 0.91 HPGD (0.40) HPGDCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL23623261 0.90 HPGD (0.41) HPGDCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL23623300 0.85 KMT2A (0.42) HPGDSMN1; SMN2ALDH1A1CHEK1KDM4E
SCHEMBL23623315 0.82 ERCC1 (0.38) HPGDCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL23623630 0.81 DRD2 (0.43) ALDH1A1
SCHEMBL23623308 0.80 KMT2A (0.41) HPGDCHEK1KDM4ENPC1HDAC3
SCHEMBL23611743 0.79 ERCC1 (0.37) HPGDALDH1A1GRK6ERCC1FEN1
SCHEMBL29930728 0.79 ERCC1 (0.37) HPGDALDH1A1GRK6ERCC1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085056-A1 POLYCYCLIC AMIDES AS UBE2K MODULATORS FOR TREATING CANCER Berg LLC (US) 2022-11-09 EP disclosed
CN-115210229-A Polycyclic amides as UBE2K modulators for the treatment of cancer 博格有限责任公司 2022-10-18 CN disclosed